A US foreign investment watchdog has approved SK hynix Inc's acquisition of Intel Corp.'s NAND business.
SK hynix signed a deal last October to buy Intel's non-volatile memory unit for US$9 billion, which includes the solid-state drive business and a NAND flash chip plant in Dalian, China.
Following the deal, the South Korean chipmaker still needs to obtain approvals from antitrust regulators in major countries.
Intel's acquisition had to be reviewed by the Committee on Foreign Investment in the United States (CFIUS) and the Federal Trade Commission (FTC). SK hynix passed the FTC's review last year.
SK hynix will make an initial payment to Intel of $7 billion after the completion of governmental approvals late this year. It will pay the remaining $2 billion to Intel by March 2025.
SK hynix's acquisition of Intel's NAND business is projected to catapult it from being the world's fourth-largest NAND flash producer to second-largest, just behind Samsung Electronics Co.
SK hynix had a market share of 11.6 percent in the fourth quarter of 2020.


China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
Coles Group Q3 Sales Rise Driven by Supermarkets and E-Commerce Growth
Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings
Alphabet Earnings Surge on AI Growth, Cloud Revenue, and Strong Search Performance
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand
Google Secures Pentagon AI Deal for Classified Projects
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand
GameStop Eyes eBay Acquisition as Stock Prices Surge After Hours
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift
Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth 



